Utah Center for Nanomedicine, Nano Institute of Utah, University of Utah, 36 S. Wasatch Drive, Salt Lake City, Utah 84112, United States.
ACS Nano. 2013 Mar 26;7(3):1961-73. doi: 10.1021/nn304439f. Epub 2013 Feb 22.
In order to engineer safer nanomaterials, there is a need to understand, systematically evaluate, and develop constructs with appropriate cellular uptake and intracellular fates. The overall goal of this project is to determine the uptake patterns of silica nanoparticle geometries in model cells, in order to aid in the identification of the role of geometry on cellular uptake and transport. In our experiments we observed a significant difference in the viability of two phenotypes of primary macrophages; immortalized macrophages exhibited similar patterns. However, both primary and immortalized epithelial cells did not exhibit toxicity profiles. Interestingly uptake of these geometries in all cell lines exhibited very different time-dependent patterns. A screening of a series of chemical inhibitors of endocytosis was performed to isolate the uptake mechanisms of the different particles. The results show that all geometries exhibit very different uptake profiles and that this may be due to the orientation of the nanoparticles when they interact with the cell surface. Additionally, evidence suggests that these uptake patterns initialize different downstream cellular pathways, dependent on cell type and phenotype.
为了设计更安全的纳米材料,我们需要了解、系统评估并开发具有适当细胞摄取和细胞内命运的结构。本项目的总体目标是确定模型细胞中不同形状的二氧化硅纳米颗粒的摄取模式,以便于确定形状对细胞摄取和转运的作用。在我们的实验中,我们观察到两种原代巨噬细胞表型的活力有显著差异;永生化巨噬细胞表现出相似的模式。然而,原代和永生化上皮细胞均未表现出毒性特征。有趣的是,所有细胞系对这些结构的摄取表现出非常不同的时变模式。我们对一系列胞吞作用的化学抑制剂进行了筛选,以分离不同颗粒的摄取机制。结果表明,所有结构都表现出非常不同的摄取模式,这可能是由于纳米颗粒与细胞表面相互作用时的取向不同。此外,有证据表明,这些摄取模式会根据细胞类型和表型启动不同的下游细胞途径。